Neoadjuvant Radiochemotherapy for Borderline and Locally Advanced Pancreatic Cancer Is a Promising Strategy to Improve Surgical Resection Rates and Outcome

To evaluate the surgery rates and the overall and disease-free survival of patients with borderline or locally advanced pancreatic cancer treated by concomitant radiochemotherapy. This monocentric retrospective study of a prospective observational cohort included all patients treated from 2010 to 2014 for borderline and locally advanced pancreatic cancer. Treatment strategy was decided in multidisciplinary staff and consisted in chemotherapy...